HCID 86693521, compound → HCID 86693565, compound
Reaction equation
I[C:2]1[CH:18]=[CH:17][C:5]2[O:6][CH2:7][CH2:8][C:9]3[N:10]([N:11]=[C:12]([C:14]([NH2:16])=[O:15])[CH:13]=3)[C:4]=2[CH:3]=1.[C:19]([C:21]1([OH:28])[CH2:25][CH:24]([CH3:26])[NH:23][C:22]1=[O:27])#[CH:20]>>[OH:28][C:21]1([C:19]#[C:20][C:2]2[CH:18]=[CH:17][C:5]3[O:6][CH2:7][CH2:8][C:9]4[N:10]([N:11]=[C:12]([C:14]([NH2:16])=[O:15])[CH:13]=4)[C:4]=3[CH:3]=2)[CH2:25][CH:24]([CH3:26])[NH:23][C:22]1=[O:27]Participants
3
Procedure
Similar to as described in General Procedure G, 9-iodo-4,5-dihydrobenzo[b]pyrazolo[1,5-d][1,4]oxazepine-2-carboxamide was reacted with a ˜1:1 diastereomeric mixture of 3-ethynyl-3-hydroxy-5-methylpyrrolidin-2-one to give a mixture of titled compounds after purification by HPLC.
Workup
- customto give
- additiona mixture of titled compounds
- customafter purification by HPLC
Sources & evidence
- ORD record
- ord-1deaa9c834fa42b4a6c15b0fc89381a1
- Source dataset
- uspto-grants-2015_05
- Patent number
- US09034866B2
Reaction notes
Loading…